Journal of Clinical Oncology, Vol 19, Issue 19
(October), 2001: 3944-3950
© 2001 American Society for Clinical Oncology
Molecular Screening for Hereditary Nonpolyposis Colorectal Cancer: A Prospective, Population-Based Study
By Antonio Percesepe,
Francesca Borghi,
Mirco Menigatti,
Lorena Losi,
Moira Foroni,
Carmela Di Gregorio,
Giuseppina Rossi,
Monica Pedroni,
Elisa Sala,
Fabiana Vaccina,
Luca Roncucci,
Piero Benatti,
Alessandra Viel,
Maurizio Genuardi,
Giancarlo Marra,
Paula Kristo,
Paivi Peltomäki,
Maurizio Ponz de Leon
From the Departments of Internal Medicine and Pathology, University of Modena, Modena; Division of Pathology, Ospedale di Carpi, Carpi; Division of Experimental Oncology I, Centro Riferimento Oncologico, Aviano; and Department of Medical Genetics, Catholic University of Rome, Rome, Italy; Institute for Medical Radiobiology, University of Zurich, Switzerland; Department of Medical Genetics, Haartman Institute, University of Helsinki, Finland; and Division of Human Cancer Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH.
Address reprint requests to Antonio Percesepe, MD, PhD, Department of Internal Medicine, University of Modena, Via del Pozzo 71, 41100 Modena, Italy; email: percesepe.antonio{at}unimo.it
PURPOSE: Germline mutations in mismatch repair genes predispose to hereditary nonpolyposis colorectal cancer (HNPCC). To address effective screening programs, the true incidence of the disease must be known. Previous clinical investigations reported estimates ranging between 0.5% and 13% of all the colorectal cancer (CRC) cases, whereas biomolecular studies in Finland found an incidence of 2% to 2.7% of mutation carriers for the disease. The aim of the present report is to establish the frequency of the disease in a high-incidence area for colon cancer.
PATIENTS AND METHODS: Through the data of the local CRC registry, we prospectively collected all cases of CRC from January 1, 1996, through December 31, 1997 (N = 391). Three hundred thirty-six CRC cases (85.9% of the incident cases) were screened for microsatellite instability (MSI) with six to 12 mono- and dinucleotide markers. MSI cases were subjected to MSH2 and MLH1 germline mutation analysis and immunohistochemistry; the methylation of the promoter region was studied for MLH1.
RESULTS: Twenty-eight cases (8.3% of the total) showed MSI. MSI cases differed significantly from microsatellite-stable (MSS) cases for their proximal location (P < .01), high mucinous component (P < .01), and poor differentiation (P = .002). Of MSI cases studied (n = 12), only one with a family history compatible with HNPCC had a germline mutation (in MSH2). Five other patients with a family history of HNPCC (two with MSI and three with MSS tumors) did not show germline mutations.
CONCLUSION: We conclude that the incidence of molecularly confirmed HNPCC (one [0.3%] of 336) in a high-incidence area for CRC is lower than in previous biomolecular and clinical estimates.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Maeda, R. R. Cannom, R. W. Beart Jr, and D. A. Etzioni
Decision Model of Segmental Compared With Total Abdominal Colectomy for Colon Cancer in Hereditary Nonpolyposis Colorectal Cancer
J. Clin. Oncol.,
March 1, 2010;
28(7):
1175 - 1180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ogino and A. Goel
Molecular Classification and Correlates in Colorectal Cancer
J. Mol. Diagn.,
January 1, 2008;
10(1):
13 - 27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chen, W. Wang, S. Lee, K. Nafa, J. Lee, K. Romans, P. Watson, S. B. Gruber, D. Euhus, K. W. Kinzler, et al.
Prediction of germline mutations and cancer risk in the Lynch syndrome.
JAMA,
September 27, 2006;
296(12):
1479 - 1487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Goecke, K. Schulmann, C. Engel, E. Holinski-Feder, C. Pagenstecher, H. K. Schackert, M. Kloor, E. Kunstmann, H. Vogelsang, G. Keller, et al.
Genotype-Phenotype Comparison of German MLH1 and MSH2 Mutation Carriers Clinically Affected With Lynch Syndrome: A Report by the German HNPCC Consortium
J. Clin. Oncol.,
September 10, 2006;
24(26):
4285 - 4292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ollikainen, W. M. Abdel-Rahman, A.-L. Moisio, A. Lindroos, R. Kariola, I. Jarvela, M. Poyhonen, R. Butzow, and P. Peltomaki
Molecular Analysis of Familial Endometrial Carcinoma: A Manifestation of Hereditary Nonpolyposis Colorectal Cancer or a Separate Syndrome?
J. Clin. Oncol.,
July 20, 2005;
23(21):
4609 - 4616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chen, P. Watson, and G. Parmigiani
Accuracy of MSI testing in predicting germline mutations of MSH2 and MLH1: a case study in Bayesian meta-analysis of diagnostic tests without a gold standard
Biostat.,
July 1, 2005;
6(3):
450 - 464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hampel, W. L. Frankel, E. Martin, M. Arnold, K. Khanduja, P. Kuebler, H. Nakagawa, K. Sotamaa, T. W. Prior, J. Westman, et al.
Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)
N. Engl. J. Med.,
May 5, 2005;
352(18):
1851 - 1860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Pinol, A. Castells, M. Andreu, S. Castellvi-Bel, C. Alenda, X. Llor, R. M. Xicola, F. Rodriguez-Moranta, A. Paya, R. Jover, et al.
Accuracy of Revised Bethesda Guidelines, Microsatellite Instability, and Immunohistochemistry for the Identification of Patients With Hereditary Nonpolyposis Colorectal Cancer
JAMA,
April 27, 2005;
293(16):
1986 - 1994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Oda, Y. Maehara, Y. Ikeda, E. Oki, A. Egashira, Y. Okamura, I. Takahashi, Y. Kakeji, Y. Sumiyoshi, K. Miyashita, et al.
Two modes of microsatellite instability in human cancer: differential connection of defective DNA mismatch repair to dinucleotide repeat instability
Nucleic Acids Res.,
March 18, 2005;
33(5):
1628 - 1636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J R Jass, L Roncucci, M Ponz de Leon, P Benatti, F Borghi, M Pedroni, A Scarselli, C di Gregorio, L Losi, A Viel, et al.
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) * Author's reply
Gut,
July 1, 2004;
53(7):
1055 - 1056.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Umar, C. R. Boland, J. P. Terdiman, S. Syngal, A. d. l. Chapelle, J. Ruschoff, R. Fishel, N. M. Lindor, L. J. Burgart, R. Hamelin, et al.
Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
J Natl Cancer Inst,
February 18, 2004;
96(4):
261 - 268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Ponz de Leon, P Benatti, F Borghi, M Pedroni, A Scarselli, C Di Gregorio, L Losi, A Viel, M Genuardi, G Abbati, et al.
Aetiology of colorectal cancer and relevance of monogenic inheritance
Gut,
January 1, 2004;
53(1):
115 - 122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W H de Vos tot Nederveen Cappel, E Buskens, P van Duijvendijk, A Cats, F H Menko, G Griffioen, J F Slors, F M Nagengast, J H Kleibeuker, and H F A Vasen
Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect
Gut,
December 1, 2003;
52(12):
1752 - 1755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Colombino, A. Cossu, A. Arba, A. Manca, A. Curci, A. Avallone, G. Comella, G. Botti, F. Scintu, M. Amoruso, et al.
Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting for MLH1 and MSH2 inactivation in familial cases
Ann. Onc.,
October 1, 2003;
14(10):
1530 - 1536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Peltomaki
Role of DNA Mismatch Repair Defects in the Pathogenesis of Human Cancer
J. Clin. Oncol.,
March 15, 2003;
21(6):
1174 - 1179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Cui, M. Cruz-Correa, F. M. Giardiello, D. F. Hutcheon, D. R. Kafonek, S. Brandenburg, Y. Wu, X. He, N. R. Powe, and A. P. Feinberg
Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
Science,
March 14, 2003;
299(5613):
1753 - 1755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. de Jong, I. M. Nolte, G. J. te Meerman, W. T. A. van der Graaf, E. G. E. de Vries, R. H. Sijmons, R. M. W. Hofstra, and J. H. Kleibeuker
Low-penetrance Genes and Their Involvement in Colorectal Cancer Susceptibility
Cancer Epidemiol. Biomarkers Prev.,
November 1, 2002;
11(11):
1332 - 1352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. Samowitz, M. L. Slattery, E. Porfiri, M. Scartozzi, A. Piga, and R. Cellerino
Missense Mismatch Repair Gene Alterations, Microsatellite Instability, and Hereditary Nonpolyposis Colorectal Cancer
J. Clin. Oncol.,
July 15, 2002;
20(14):
3178 - 3179.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Andermann, I. Thiffault, N. Wong, P. Gordon, E. MacNamara, G. Chong, W. Foulkes, A. Percesepe, M. Ponz de Leon, and P. Peltomaki
Multimodal Molecular Screening Is Required to Improve the Sensitivity of MLH1 and MSH2 Mutation Analysis
J. Clin. Oncol.,
March 15, 2002;
20(6):
1705 - 1707.
[Full Text]
[PDF]
|
 |
|
|